These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 26038300

  • 1. Classical pathway deficiencies - A short analytical review.
    Truedsson L.
    Mol Immunol; 2015 Nov; 68(1):14-9. PubMed ID: 26038300
    [Abstract] [Full Text] [Related]

  • 2. [Lupus and protein deficiencies of the classical complement pathway].
    Weiss L, Maillet F, Kazatchkine M.
    Rev Prat; 1990 Sep 21; 40(21):1937-40. PubMed ID: 2237185
    [Abstract] [Full Text] [Related]

  • 3. Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.
    Hartmann D, Fremeaux-Bacchi V, Weiss L, Meyer A, Blouin J, Hauptmann G, Kazatchkine M, Uring-Lambert B.
    J Clin Immunol; 1997 Mar 21; 17(2):176-84. PubMed ID: 9083894
    [Abstract] [Full Text] [Related]

  • 4. Inherited complement deficiency states and SLE.
    Rynes RI.
    Clin Rheum Dis; 1982 Apr 21; 8(1):29-47. PubMed ID: 6288318
    [No Abstract] [Full Text] [Related]

  • 5. Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus.
    Liphaus BL, Umetsu N, Jesus AA, Bando SY, Silva CA, Carneiro-Sampaio M.
    Clinics (Sao Paulo); 2015 Mar 21; 70(3):220-7. PubMed ID: 26017655
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.
    Hart ML, Ceonzo KA, Shaffer LA, Takahashi K, Rother RP, Reenstra WR, Buras JA, Stahl GL.
    J Immunol; 2005 May 15; 174(10):6373-80. PubMed ID: 15879138
    [Abstract] [Full Text] [Related]

  • 7. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
    Gullstrand B, Mårtensson U, Sturfelt G, Bengtsson AA, Truedsson L.
    Clin Exp Immunol; 2009 May 15; 156(2):303-11. PubMed ID: 19302245
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous manifestations of complement deficiencies.
    Lipsker D, Hauptmann G.
    Lupus; 2010 Aug 15; 19(9):1096-106. PubMed ID: 20693203
    [Abstract] [Full Text] [Related]

  • 11. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients.
    Jesus AA, Liphaus BL, Silva CA, Bando SY, Andrade LE, Coutinho A, Carneiro-Sampaio M.
    Lupus; 2011 Oct 15; 20(12):1275-84. PubMed ID: 21813590
    [Abstract] [Full Text] [Related]

  • 12. [Hereditary complement deficiencies].
    Fischer E.
    Hautarzt; 1982 Feb 15; 33(2):65-72. PubMed ID: 6281215
    [Abstract] [Full Text] [Related]

  • 13. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
    Garred P, Mollnes TE, Thorsteinsson L, Erlendsson K, Steinsson K.
    Scand J Immunol; 1990 Jan 15; 31(1):59-64. PubMed ID: 2300790
    [Abstract] [Full Text] [Related]

  • 14. Complement deficiency and autoimmunity.
    Sullivan KE.
    Curr Opin Pediatr; 1998 Dec 15; 10(6):600-6. PubMed ID: 9848020
    [Abstract] [Full Text] [Related]

  • 15. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F, Goetz J, Hauptmann G, Clauvel JP, Mery JP, Kahn MF, Kazatchkine M.
    Presse Med; 1987 Mar 07; 16(8):378-82. PubMed ID: 2950498
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM.
    J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630
    [Abstract] [Full Text] [Related]

  • 20. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.
    Mitchell DA, Taylor PR, Cook HT, Moss J, Bygrave AE, Walport MJ, Botto M.
    J Immunol; 1999 May 15; 162(10):5676-9. PubMed ID: 10229798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.